Hey guys! Today's episode is more of a fast rant on the recent press release about MindMed raising ANOTHER $19.5M from Canaccord Genuity Corp, on a deal that is set to close tomorrow, March 9th.
Here, I'm discussing:
1. The number MindMed shares being sold and their respective price;
2.Why is MindMed doing this?
3. Potential short term and long term effects on MMED's stock price
4. Nasdaq uplisting?
5. Market crash thoughts
I hope you guys found some value in this and I'll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #MMEDNews
Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression
TreatmentBeckley Psytech Explores Psilocybin for Headache Treatment
Research, TreatmentAtma Journey Centers Opens First Clinic In Calgary, Alberta
PodcastsCanada’s First End of Life Psilocybin Treatment Brought Peace to Terminal Man
Culture, TreatmentAre ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits
ResearchNorth America Is Poised to Take the Lead In Emerging Psychedelic Drugs Market
Business, PolicyCan An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes
Business, CultureMinority Veterans Organization Urges Congress to Loosen Restrictions on Psychedelic Therapies
Culture, TreatmentMindMed Raises $19.5 Million // What Does This Mean for MMEDF/MMED? [Plus Upcoming Market CRASH?]
VideosAre Microdosing Benefits Real? A New Study Says It May All Be In Your Mind
Microdosing, Research